
    
      This is a prospective, randomized, double-blind clinical study comparing safety and efficacy
      of the treatments performed with Renova (LI-ESWT) on symptomatic ED patients to the safety
      and efficacy of the control sham patients. Patients are randomized in a 1:1 ratio of Renova
      to the sham control group.
    
  